GSTM1 and chronic kidney disease: Given these considerations, our study aims to compare the efficacy of oral liposomal iron versus IV iron in treating anemia in non-dialysis CKD patients in terms of iron status during treatment, Hb levels, speed of Hb correction, and therapeutic tolerance.